Successful treatment with tocilizumab of a psoriasiform skin lesion induced by etanercept in a patient with juvenile idiopathic arthritis

Mod Rheumatol. 2015;25(6):972-3. doi: 10.3109/14397595.2014.985812. Epub 2014 Dec 15.

Authors

Masaki Shimizu¹, Yasuhito Hamaguchi², Sayaka Ishikawa¹, Kazuyuki Ueno¹, Akihiro Yachie¹

Affiliations

¹ a Department of Pediatrics , School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University , Kanazawa , Japan.
² b Department of Dermatology , School of Medicine, Institute of Medical, Pharmaceutical and Health Sciences, Kanazawa University , Kanazawa , Japan.

PMID: 25496406
DOI: 10.3109/14397595.2014.985812

No abstract available

Keywords: Etanercept; Juvenile idiopathic arthritis; Psoriasiform skin lesions; Tocilizumab.

Publication types

Case Reports
Letter

MeSH terms

Antibodies, Monoclonal, Humanized / therapeutic use*
Antirheumatic Agents / adverse effects*
Arthritis, Juvenile / drug therapy*
Etanercept / adverse effects*
Female
Humans
Psoriasis / chemically induced*
Psoriasis / drug therapy*
Young Adult

Substances

Antibodies, Monoclonal, Humanized
Antirheumatic Agents
tocilizumab
Etanercept